Cmax Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
About Cmax Life Sciences
Cmax Life Sciences Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2019 (Five years and four months 5 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Gautam Bhattacharjee, Haren Borah, Anirban Bhagowati, and Two other members serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304AS2019PTC019578
-
Company No.
019578
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Cmax Life Sciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Bhattacharjee
|
Director | 09-Nov-2019 | Current |
|
Haren Borah
|
Director | 09-Nov-2019 | Current |
|
Anirban Bhagowati
|
Director | 09-Nov-2019 | Current |
|
Bhaskar Goswami
|
Director | 09-Nov-2019 | Current |
|
Pulin Brahma
|
Director | 10-Oct-2019 | Current |
Financial Performance of Cmax Life Sciences.
Cmax Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cmax Life Sciences?
Unlock access to Cmax Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cmax Healthcare LlpGautam Bhattacharjee, Bhaskar Goswami and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cmax Life Sciences?
Unlock and access historical data on people associated with Cmax Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cmax Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cmax Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
